Research

Slowing down progression using current drugs to be tested

Minister says legislation is at an ‘advanced stage’

The annual infusion therapy Lemtrada moves closer to approval.

How do you build relationships at home, work and in your community?

The UL hosted event focused on a range of mobility issues and novel interventions

Small trial suppressing anti-myelin immune responses shows promise 

Event open to health professionals working in MS rehabilitation

TECFIDERA (BG-12) is approved in the US

Recruiting Now

Cognitive impairment differs between primary progressive and relapsing-remitting MS